GeriQBank · Paper IV · Q12
Urinary Tract Infection in the Elderly
- Chapter
- Endocrine, Metabolic, Renal & Genitourinary Systems
- Years asked
- Not recorded in the source
- Frequency
- Set 1× in Paper IV (2009–2025)
As set in the university paper
Urinary tract infection in the elderly.
Paper IV · Renal, Genitourinary, Continence & Men's Health · asked ×1 · 6-mark note · see in paper list
Detailed answer
Pro · free in betaAttempt it firstOutline your answer as a 6-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer
A. Epidemiology and Definitions
UTI is the most common infection in the elderly, and is especially frequent in debilitated and institutionalised individuals; it is the commonest source of bacteraemia in older adults.
Uncomplicated UTI occurs in a structurally and functionally normal tract; complicated UTI occurs with obstruction, stones, catheters, neurogenic bladder, renal impairment, immunosuppression or male sex — most UTI in older people is complicated.
Catheter-associated UTI (CA-UTI) and urosepsis are the two forms with the greatest mortality.
B. Predisposing Factors
Obstructive uropathy is the key mechanism — prostatic hypertrophy in men, prolapse and cystocele in women, stones and strictures in both.
Non-obstructive factors: vaginal and urethral atrophy, puddling of urine from bed rest, bladder catheterisation, incomplete emptying with a raised post-void residual, and faecal incontinence.
Host factors: diabetes, immunosenescence with reduced cell-mediated and humoral immunity, malnutrition, dementia and functional dependence.
Phagocytic function and the complement system appear unaltered in ageing; the defect is largely mechanical and mucosal rather than immunological.
C. Microbiology
E. coli remains the commonest organism, but the frequency of Gram-negative bacilli other than E. coli increases with age — Proteus, Klebsiella, Pseudomonas, Serratia — along with Enterococcus and, in catheterised patients, polymicrobial flora.
Proteus mirabilis is urease-producing and causes alkaline urine, struvite stones and catheter encrustation.
If Staphylococcus aureus is grown from urine, take blood cultures — it usually reflects bacteraemic seeding of the kidney rather than ascending infection.
In India, ESBL-producing Enterobacterales are widespread, with high resistance to fluoroquinolones and third-generation cephalosporins, and rising carbapenem resistance in hospital-acquired infection.
D. Clinical Presentation
Classical dysuria, frequency and urgency may be absent; presentation is often atypical — confusion or delirium, functional decline, falls, anorexia, incontinence, or unexplained fever.
Fever may be blunted or absent; conversely, in the very old a febrile response is more likely to indicate bacterial rather than viral illness. Absence of leucocytosis does not exclude bacterial infection.
Acute unexplained functional deterioration should alert the physician to a potential acute infectious process.
Nevertheless, non-specific symptoms alone should not be attributed to UTI unless other causes have been excluded — this is the central diagnostic discipline in geriatric practice.
Acute pyelonephritis presents with fever, rigors, loin pain and vomiting; in the elderly it may present simply as collapse or sepsis.
E. Diagnosis and Management
Send a properly collected specimen: clean-catch midstream, or a fresh condom-catheter specimen in incontinent men after cleaning; catheterised patients should have the sample taken from a freshly changed catheter, never from the drainage bag.
Dipstick negative for both nitrites and leucocyte esterase makes cystitis very unlikely; a positive dipstick alone does not establish infection in an older patient.
Treatment principles: choose according to the organism isolated and local resistance patterns; empirical cover should account for the higher frequency of Gram-negative organisms, and renal function must be considered and monitored, particularly with aminoglycosides.
Typical regimens: nitrofurantoin 100 mg twice daily for 5–7 days (avoid if eGFR <45 mL/min) or fosfomycin 3 g single dose for lower UTI in women; 7 days for men; 7–14 days for pyelonephritis with an aminoglycoside or third-generation cephalosporin initially, stepped down by culture; carbapenem or a beta-lactam/beta-lactamase inhibitor for ESBL infection.
Fluoroquinolones should be avoided in older adults where possible — tendon rupture, aortic aneurysm, QT prolongation, delirium, hypoglycaemia and C. difficile.
Supportive care: hydration, review of drugs, treatment of constipation, catheter removal, delirium prevention, and early mobilisation. Investigate for obstruction, stone or abscess if fever persists beyond 72 hours.
Prevention: adequate fluid intake, vaginal oestrogen, avoidance of unnecessary catheterisation, prompt catheter removal, bladder emptying strategies, and not treating asymptomatic bacteriuria.
Latest Updates (2023–Present)
EAU Urological Infections Guideline (2023–2025) and IDSA guidance now foreground antimicrobial stewardship: culture-directed narrow-spectrum therapy, shortest effective duration, and avoidance of fluoroquinolones as first-line agents.
Diagnostic stewardship tools (Loeb minimum criteria, McGeer criteria, AHRQ decision aid) are recommended in long-term care to decide when to send urine, not merely when to treat.
The “continuum of UTI” concept (2023–2024) formally accommodates the older patient with bacteriuria and non-localising symptoms, encouraging short-term observation and reassessment in stable patients. New antimicrobials for resistant uropathogens: gepotidacin (approved 2025 for uncomplicated UTI, a novel oral class), and for complicated UTI ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam, imipenem-relebactam, plazomicin, cefiderocol and cefepime-taniborbactam — most relevant to Indian tertiary practice with high ESBL and carbapenemase burden.
Nitrofurantoin has been re-evaluated as safe down to an eGFR of about 30–45 mL/min for short courses, widening its use in older women, though long-term prophylaxis remains restricted. Randomised evidence continues to support shorter courses: 5 days of nitrofurantoin for cystitis, 7 days for febrile UTI in men where source control is achieved.
Indian data consistently show >50% fluoroquinolone resistance and 40–60% ESBL rates in community E. coli isolates, making empirical fluoroquinolone or cephalosporin use inappropriate; nitrofurantoin and fosfomycin remain the reliable oral options.
Current Practice Update
Aspect Textbook Position Current Evidence / Guideline Empirical therapy Third-generation cephalosporin and/or Culture-directed, narrow-spectrum; aminoglycoside fluoroquinolones and cephalosporins unreliable in India Nitrofurantoin in renal impairment Avoided in renal impairment Acceptable for short courses down to eGFR ~30–45 mL/min Duration Conventional courses Shorter courses — 5 days cystitis, 7 days in men, 7–14 days pyelonephritis Non-specific symptoms Atypical presentation is typical Balanced by diagnostic stewardship — do not over-attribute delirium/falls to UTI Resistant organisms Not addressed New agents — gepotidacin, and beta-lactam/beta-lactamase inhibitor combinations Deciding to test Send urine if UTI suspected Loeb/McGeer/AHRQ criteria determine when to send urine at all Exam One-Liners UTI is the commonest infection in the elderly; obstructive uropathy is the key mechanism.
E. coli commonest, but non-E. coli Gram-negatives rise with age.
A urine growing S. aureus demands blood cultures.
Negative nitrite plus negative leucocyte esterase virtually excludes cystitis.
Avoid fluoroquinolones in older adults; nitrofurantoin and fosfomycin are the workhorses. Atypical presentation is the rule — but do not blame every delirium on the urine.
How was your recall?
Rating marks the question complete. “Need another pass” also adds it to your bookmarks.
References
- PAPERS-2-3-4_COMBINED.pdf — page 1202
- GeriQBank source PDF — p. 1202
Spotted an error or something out of date?Report a problem with this page